SCHEMBL17059595

SCHEMBL17059595

O=C(Nc1cccc([N+](=O)[O-])c1)Nc1ccnc(Cl)n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.64
MEN1 O00255 7/20 0.64
MAPT P10636 5/20 0.64
HTT P42858 4/20 0.64
POLB P06746 3/20 0.64
CTDSP1 Q9GZU7 2/20 0.64
DDX3X O00571 2/20 0.64
BAZ1A Q9NRL2 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
ALDH1A1 P00352 3/20 0.57
LMNA P02545 2/20 0.57
GAA P10253 2/20 0.54
CNR1 P21554 1/20 0.54
MAPK1 P28482 3/20 0.54
CA12 O43570 2/20 0.52
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
CA9 Q16790 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13859262 0.84 ROCK1 (0.72) KMT2AMEN1MAPTPOLBSMN1; SMN2
SCHEMBL1047211 0.80 MEN1 (1.00) KMT2AMEN1MAPTHTTPOLB
SCHEMBL17059591 0.80 DDX3X (0.60) KMT2AMEN1MAPTHTTPOLB
SCHEMBL17059657 0.80 KMT2A (0.54) KMT2AMEN1MAPTHTTPOLB
SCHEMBL17084065 0.79 MEN1 (0.96) KMT2AMEN1MAPTHTTPOLB
SCHEMBL29494959 0.78 MAPT (0.82) KMT2AMEN1MAPTHTTPOLB
SCHEMBL22092648 0.78 MAPT (0.82) KMT2AMEN1MAPTHTTPOLB
SCHEMBL23065786 0.77 KMT2A (0.62) KMT2AMEN1MAPTHTTNPC1
SCHEMBL17059588 0.77 EGFR (0.61)
SCHEMBL17059598 0.77 EGFR (0.69) KMT2AMEN1MAPTHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015127873-A1 ARYLAMINO PYRAMIDINE COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS PREPARED THEREFROM 上海海雁医药科技有限公司 2015-09-03 WO disclosed